Navigation Links
Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
Date:9/23/2009

rocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements by Oxygen Biotherapeutics, Inc. that involve risks and uncertainties and reflect the company's judgment as of the date of this release. These statements include those referring to the start of a Phase II for Oxycyte in TBI. Actual events or results may differ from Oxygen Biotherapeutics, Inc.'s expectations. There can be no assurance that a sufficient number of patients will be enrolled in the trial nor any assurance of the outcomes. Additional information concerning these and other risk factors affecting Oxygen Biotherapeutics, Inc.'s business can be found in the company's public periodic filings with the Securities and Exchange Commission, which are available via www.oxybiomed.com. Oxygen Biotherapeutics, Inc. disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
2. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
3. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
6. Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
7. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
8. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
9. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
10. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
11. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... wearable injector slightly larger than an Oreo cookie may soon ... drugs in the large doses required to treat a wide ... genetic disorders.  An emerging biologic drugs market ... analysts.   Many of these drugs will require a new type ...
(Date:1/14/2014)... BEVERLY HILLS, Calif. , Jan. 14, 2014 The Brandeis ... Los Angeles a premier and affordable laser tattoo ... treatment special. Dr. Brandeis, focus is in providing high quality cosmetic ... to all patients. " Southern California ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ergonomically ... with Hitachi Koki of Japan ... North America . NuAire will utilize its network of ... Canada to offer assistance in application use, ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 1, 2011 Every year thousands of children are hospitalized ... for them. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Teens share ... by colorful pills that look like candy. ... how you can prevent harm by locking your medicine up. ...
... N.J., Nov. 1, 2011 Quest Diagnostics Incorporated (NYSE: ... diagnostic testing, information and services, today announced the CE ... & RSV Direct test on the 3M™ Integrated Cycler. ... uses a proprietary technique to eliminate nucleic-acid sample extraction, ...
Cached Medicine Technology:Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 2Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 3
(Date:4/23/2014)... WEST LAFAYETTE, Ind. - Purdue University researchers have developed ... a living cell by using tiny gold particles with ... Irudayaraj, professor of agricultural and biological engineering, used gold ... material known as BRCA1 messenger RNA splice variants, which ... The number of these mRNA splice variants in a ...
(Date:4/23/2014)... which patients might suffer potentially fatal side-effects from a ... brain scans using pattern recognition software similar to that ... developed by researchers at Imperial College London. Results of ... used the software are published in the journal ... million people each year worldwide. Ischemic strokes are the ...
(Date:4/23/2014)... a country as wealthy as the United States, it may ... not have access to adequate food due to lack of ... , Recent research at the University of Illinois using data ... that the seniors who are dealing with hunger are also ... 8.35 percent of Americans over age 60 faced the threat ...
(Date:4/23/2014)... journal Oncotarget , explored tumour heterogeneity ... own DNA signatures within the same cancer. Such ... targeted treatment strategies. , Firstly they confirmed the ... the KRAS or BRAF mutation. Secondly, they found ... mutation have that specific mutation present uniformly throughout ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
Breaking Medicine News(10 mins):Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:More Americans in their golden years are going hungry 2Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2
... 3 Yesterday in a historical,and unprecedented move, ... for House Bill 1150 to mandate commercial,insurance companies ... The,bill, introduced by House Speaker Dennis M. O,Brien, ... autism-related treatment for,individuals less than 21 years old., ...
... 3 Mergent, Inc., administrator for the,HealthShares(TM) Indexes, ... Exchange Traded Funds, today announced the following,change effective ... 9, 2008: ISTA,Pharmaceuticals (Nasdaq: ISTA ) will ... Ophthalmology Index. Jerini AG is being,acquired by Shire ...
... Enterprises of,Shijiazhuang, China, the world,s largest manufacturer of vinyl ... notified Medline,Industries, Inc., and other U.S. customers that they ... unable to meet their normal,agreements to customers. Hong Ray ... to supply will have a cost impact on the ...
... Details Support for Community Organizations, SOUTH PORTLAND, ... Shield donated more than $1.4 million to community ... charitable,activities are detailed in the recently released Maine ... found online at, http://www.anthem.com/maine/communityreport ., "All associates ...
... Triple-S,Management Corporation (NYSE: GTS ) today announced that ... quarter ended June 30, 2008,before the market opens on ... Officer, and Juan-Jose Roman, Finance Vice President,and Chief Financial ... and the outlook for the company at 10:00 a.m. ...
... Ro to Promote Circle of Promise ... #401, DALLAS, July 3 , WHAT: Circle of ... Brock (Dr. Ro) will bring the fight against breast cancer to ... their view on breast cancer in the ...
Cached Medicine News:Health News:Pennsylvania Tells Autism Speaks to Stop Talking 2Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index 2Health News:Medline Receives Force Majeure Notice From Hong Ray Enterprises 2Health News:Anthem Blue Cross and Blue Shield Issues Community Report for 2007 2Health News:Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast 2Health News:Susan G. Komen for the Cure(R)'s Circle of Promise to Mobilize African American Women Against Breast Cancer at 2008 Music Festival 2
... is a multi-tasking vacuum source and solvent ... vapor trap and a maintenance-free, oil-free vacuum ... easy-to-use, wide-mouth glass condensation flask collects all ... easy disposal. The UVS400 provides an ideal ...
... Combines BchiVac V-500 with Vacuum Controller ... Electronic switching mechanism turns V-500 on and off ... Compact Housing Model V-500 is a powerful ... applications. Applications Ideally suited for use ...
... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ... ovens, concentrators, gel dryers, and filtration apparatuses ... to chemicals and heat load Corrosion-resistant ...
... Universal Vacuum Source is a combination instrument bringing ... 4-headed, Oil-free Vacuum Pump. It is designed to ... abuse., Combines a Refrigerated Cold Trap ... eliminating extra tubing connections. , ...
Medicine Products: